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MIR: 75 YEARS OF RADIOLOGY EXPERIENCE 
m 
Visit the MIR web site at 
www.mir.wustl.edu 
In the early 1900s, radiology was considered by most medical 
practitioners as nothing more than photography. In this 75th 
year of Mallinckrodt Institute's existence, the first of a three-part 
series of articles will chronicle the rapid advancement of radiol- 
ogy at Washington University and the emergence of MIR as a 
world leader in the field of radiology. 
THE METABOLISM OF THE DIABETIC HEART 
More diabetic patients die from cardiovascular 
disease than from any other cause. Researchers in 
the Institute's Cardiovascular Imaging Laboratory 
are finding that the heart's metabolism may be one 
of the primary mechanisms by which diseases such as 
diabetes have a detrimental effect on heart function. 
VIRTUAL C0L0N0SC0PY: A LIFESAVING TECHNOLOGY 
More than 55,000 Americans die each year from 
cancers of the colon and rectum. As part of the 
National CT Colonography Trial, MIR clinical 
researchers are evaluating new noninvasive 
technologies to make screening easier, faster, 
and more comfortable for the patient while 
providing diagnostic accuracy. 
UTERINE FIBROID EMBOLIZATION 
More than 5 million American women suffer 
with symptomatic uterine fibroids, and each year 
approximately 250,000 women undergo surgery to 
alleviate the fibroid-associated pain. Interventional 
radiologists at Mallinckrodt Institute provide a 
uterus-sparing treatment option that shrinks the 
fibroids and relieves pressure on adjacent organs. 
ON THE COVER Colon cancer is the second most deadly cancer in the United States, but 
health professionals like Christine Menias, MD, and research assistant Ruth Holdener 
(right) are working to increase awareness about colon cancer and the need for diagnostic 
screening. Photograph by Tim Parker. 
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Matching 
Program results 
announced 
In July, 18 physicians 
will begin their first year of 
training in diagnostic radiol- 
ogy. The 2006-2007 trainees 
come from these institutions: 
•Case Western Reserve 
University School of 
Medicine, Cleveland, Ohio 
•University of Alabama 
School of Medicine, 
Birmingham 
•University of Virginia 
School of Medicine, 
Charlottesville 
•Duke University School 
of Medicine, Durham, 
North Carolina 
•University of Texas 
Medical School at Houston 
•Washington University 
in St. Louis School of 
Medicine 
•Yale University School 
of Medicine, New Haven, 
Connecticut 
•University of California, 
San Francisco School 
of Medicine 
•Columbia University 
College of Physicians 
and Surgeons, New York 
City, New York 
•Vanderbilt University 
School of Medicine, 
Nashville, Tennessee 
•University of Pennsylvania 
School of Medicine, 
Philadelphia 
•University of Michigan 
School of Medicine, 
Ann Arbor. 
Siteman Cancer 
Center accepted 
into NCCN 
The Alvin J. Siteman 
Cancer Center (SCC), 
housed in the Center for 
Advanced Medicine at Wash- 
ington University Medical 
Center, is now a member of 
The National Comprehensive 
Cancer Network (NCCN). 
As an NCCN member, the 
SCC will be involved in the 
planning, development, and 
validation of therapies and 
guidelines representing the 
future of cancer care. The 
NCCN is an alliance of 20 
nationally acclaimed cancer 
centers dedicated to improv- 
ing the quality, efficiency, 
and effectiveness of 
oncology practice. 
WUSM retains 
high national 
ranking 
Since 1987, U.S. News & 
World Report has issued an 
annual ranking of profes- 
sional and graduate schools. 
Washington University in 
St. Louis School of Medicine 
(WUSM) consistently has 
placed in the top 10 schools 
and since 1998 has ranked 
first in student selectivity, 
based on both college grade- 
point averages and MCAT 
scores. According to the 
magazine's April 3, 2006 
survey, WUSM ranked fourth 
overall among research- 
oriented medical schools. 
The top schools in order are 
Harvard University; Johns 
Hopkins University; Univer- 
sity of Pennsylvania; WUSM 
and University of California, 
San Francisco (tie); Duke 
University; Stanford 
University and University 
of Washington (tie); Yale 
University; and Baylor Col- 
lege of Medicine. The U.S. 
News rankings are online at 
www.usnews.com/usnews/ 
rankguide/rghome.htm. 
Wilson Award 
presented 
The 38th annual Hugh 
M. Wilson Award for Merito- 
rious Work in Radiology 
was presented on May 19 to 
Alexander Ho, a fourth-year 
medical student. Traditionally 
given at the senior program 
following the Washington 
University in St. Louis 
School of Medicine (WUSM) 
commencement exercises, 
the Wilson Award honors 
Mallinckrodt Institute's sec- 
ond director, an advocate of 
the advancement of education. 
Ho worked with Daniel 
Brown, MD, associate pro- 
fessor of radiology and of 
surgery, in the Institute's 
interventional radiology 
section. Prior to the start of 
the interventional radiology 
elective, Ho researched 
published information on 
chemoembolization and 
neuroendocrine tumors. He 
also initiated a database of 
all patients with neuroen- 
docrine tumors who were 
treated at the Washington 
University Medical Center 
from 1991 to 2005. According 
to Brown, Ho's review was 
"extraordinary in its depth 
and has led to some impor- 
tant findings that may 
change the way patients 
with this disease process 
are treated." 
Under Brown's mentorship, 
Ho was principal investigator 
on the project "Long term 
outcomes of hepatic arterial 
chemoembolization for neu- 
roendocrine malignancy," for 
which he drafted the abstract 
and manuscript—which has 
been submitted for presentation 
at the annual Radiological 
Society of North America 
meeting in Chicago and also    I 
is being submitted to the jour- I 
nal Radiology for publication. ( 
Ho will begin his first year > 
of diagnostic radiology resi- i 
dency at Mallinckrodt Institute \ 
in July 2007, after completing a» 
preliminary training year in 
internal medicine at the Uni- 
versity of California, San Diego. 
Workshops 
address 
radiology clinical fj 
trials training 
Approximately 25 partici- 
pants attended the Clinical 
Trials Methodology Workshop. 
sponsored by the Radiological 
Society of North America 
(RSNA), held in January in 
Phoenix, Arizona. Barry Siegel. 
MD, professor of radiology 
and of medicine, and Delpliine 
Chen, MD, nuclear medicine 
resident, represented 
Mallinckrodt Institute. 
This inaugural session s 
goal was to develop the 
groundwork for a series of 
workshops for radiology, 
nuclear medicine, and radi; tior 
oncology faculty, fellows, 
and senior residents as the 
develop careers in researcl 
Ace 
org 
tot 
due 
is a 
dru 
pay 
beg 
mo 
clir 
siot 
sue 
clir 
spc 
Ass 
Re; 
Soc 
Pai 
trai 
me: 
ofi 
coi 
ses 
pre 
on* 
anc 
abe 
ho1 
ses 
clii 
F 
r< 
roc 
res 
for 
MALLINCKRODT INSTITUTE OF RADIOLOGY 1 
According to workshop 
organizers, "there is a need 
to train radiologists to con- 
duct clinical trials. Imaging 
is a critical part of many 
drug trials, and third-party 
payers and others also are 
beginning to demand much 
more rigorous data to justify 
clinical decisions." 
The RSNA training ses- 
sions will be based on the 
successful, long-running 
clinical trials workshops 
sponsored by the American 
Association for Cancer 
Research and the American 
Society of Clinical Oncology. 
Participants will receive 
training in protocol develop- 
ment for the clinical evaluation 
of imaging modalities, with 
courses including didactic 
sessions, self study, 
protocol synthesis process, 
one-on-one mentoring, 
and discussion sessions. 
For more information 
about the workshop and 
how to attend future 
sessions, go online at 
www.rsna.org/Publications/ 
rsnanews/april06/ 
clinical_april06. cfm. 
Career Fair 
Washington University in St. Louis School 
of Medicine (WUSM) held its first Career 
Fair for Clinical and Research on May 6 in 
the Farrell Learning and Teaching Center. 
Kim Whitling (shown at far left in top 
photo), manager, administrative services, 
represented Mallinckrodt Institute at the 
event that provided information about 
clinical and research opportunities in 
various WUSM departments. An estimated 
150 attendees submitted job applications. 
Faculty 
receive kudos 
The following Mallinck- 
rodt Institute clinicians and 
researchers were recognized 
for their many achievements: 
• Maurizio Corbetta, MD, 
professor of neurology, of 
radiology, and of anatomy 
and neurobiology, 
received the American 
Academy of Neurology's 
(AAN's) Norman 
Geschwind Prize for his 
outstanding research in 
the field of behavioral 
neurology. The award 
was presented at the 
AAN's annual meeting in 
April in San Diego. 
' William McAlister, MD, 
professor of radiology 
and of pediatrics, was a 
recipient of one of three 
Distinguished Service 
Awards presented by 
Washington University 
in St. Louis School of 
Medicine at the Reunion 
2006 award ceremony 
in May. 
• Kathleen McDermott, 
PhD, assistant professor of 
psychology and of radiology, 
was named an Outstand- 
ing Faculty Mentor by the 
Graduate Student Senate 
of Washington University 
in St. Louis. The award, 
established in 1999, hon- 
ors faculty who make a 
significant contribution 
to the quality of life 
and professional develop- 
ment of Arts & Sciences 
graduate students. 
1
 Marcus Raichle, MD, 
professor of radiology, of 
neurobiology, and of 
neurology, was awarded 
the honorary degree of 
Doctor of Science by the 
University of Chicago. 
The following is an excerpt 
from the nominating state- 
ment: "Widely considered the 
father of cognitive neuro- 
science, Professor Raichle's 
technical contributions to 
the field of neuroimaging 
and his research contributions 
.. .have revolutionized the 
study of brain and behavior." 
Raichle also received the 
2006 Distinguished Alumni 
Award from his alma mater, 
the University of Washington 
in Seattle. 
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early 111 years ago (November 8.1895, to be precise) 
Wilhelm Conrad Rontgen, a physics proiessor, was in his 
darkened laboratory in Wurzberg, Germany, experimenting 
with the action of electric energy in partially evacuated glass tubes. 
Alter he noticed a glow emanating from 
the far corner of the lab, Rontgen 
conducted a series of experiments, 
which culminated with passing 
his hand between a fluorescing 
screen and the tube and then 
seeing what appeared to be 
a shadow of the bones in his 
hand. He verified these 
observations by capturing 
the bone shadow 
images onto photo- 
graphic plates. The 
subsequent publishing 
of Rontgen's data in 
the Wurzberg Physico- 
Medical Society's scientific 
journal and in newspapers 
worldwide heralded the startling 
discovery of the new, unknown rays— 
referred to as X rays. 
The following article is the first of three installments that will follow 
the history of radiology at Washington University in St. Louis and the 
establishment of Mallinckrodt Institute of Radiology (MIR). In this 75th 
year of MIR's existence, it is important to honor our past, highlight the 
present, and ponder our future. Information for this and subsequent 
articles was condensed from several sources, including the booklet 
Mallinckrodt Institute of Radiology 50th Anniversary and an informal 
text prepared by Sam Merenda. MD, a St. Louis radiologist. 
'^rodtlnstm^ 
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RADIOLOGY AT 
WASHINGTON UNIVERSITY: 
PRE-MIR 
Functioning X-ray equipment 
was in place (known as the Photo- 
graphical Roentgen Ray Department) 
at Washington University before 
1900. However, the University's 
X-ray service actually came into 
existence in 1910—just 15 years 
after Rontgen's discovery—at the 
Washington University School of 
Medicine (WUSM), which was affil- 
iated with the Washington University 
Hospital on Jefferson Avenue. 
W    m   X/  /^     m    & 
The X-ray service was called the 
"Actinographic Laboratory" [no 
data is available as to why it was 
so named] and was directed by 
Russell Carman, MD, a pioneer in 
the clinical use of X rays (particu- 
larly in gastroenterology). Car- 
man's academic title was "lecturer 
in roentgenography." Following a 
reorganization of WUSM depart- 
ments in 1912 and 1913, which 
resulted in the X-ray service being 
assigned to the Department of 
Surgery, Carman became an 
instructor in roentgenology. Car- 
man left the University in late 1913 
to become head of radiology at the 
Mayo Clinic in Rochester, Minnesota, 
where he remained until his death 
in 1926. Charles Mayo, MD, and 
many other influential physicians 
at that time considered Carman "the 
leading radiologist in the country." 
Walter Mills, MD, a graduate of 
the Marion Sims-Beaumont College 
of Medicine (later known as 
Saint Louis University School of 
Medicine), succeeded Carman as 
head of radiology. He had given 
up a private general practice in 
Webster Groves, Missouri, to study 
gastroenterology in Europe. Mills 
was later affiliated with WUSM and 
the Jefferson Avenue hospital 
where he worked to develop diag- 
nostic techniques for clinical exams, 
especially the digestive system. 
He had particular expertise in 
fluoroscopy and was a pioneer in 
developing diagnostic imaging 
techniques. Following Carman's 
departure in 1913, Mills became 
head of WUSM radiology. 
In 1914, X-ray activities were 
moved from the Jefferson Avenue 
hospital to a Kingshighway Boule- 
vard facility that was affiliated with 
WUSM and Barnes Hospital. Two 
rooms (called the X-ray Laboratory), 
then considered adequate for the 
fledgling service, was established 
on the second floor of the hospital. 
A local newspaper's mention of the 
relocation called the lab "an elabo- 
rate photographic gallery for 
taking X-ray, autochrome, and 
ordinary pictures." 
A piece of diagnostic equipment, 
an X-ray generator that had been 
used at the Jefferson Avenue facility 
by Carman in his fluoroscopic 
investigations of the gastrointestinal 
tract, was moved to the new loca- 
tion and subsequently used by 
other groups in some innovative 
applications: pyleographic images, 
MALLINCKRODT INSTITUTE OF RADIOLC 
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(left to right) doctors 
Glover Copher, Evarts 
Graham, Warren Cole, and 
Sherwood Moore. 
(below) Circa 1914—X-ray 
generator used in the animal 
lab to produce X rays as 
cholecystography was being 
using sodium iodide, of the kidney, 
ureters, and bladder; first arteriogram 
on record; and the evaluation of 
animal testing that resulted in the 
development of cholecystography. 
As radiographic usage became 
more widespread, the second-floor 
quarters soon became obsolete; a 
new radiology department was 
being considered. 
In 1917, Sherwood Moore, MD, 
joined Mills at WUSM as a codirec- 
tor of the new lab. Moore had a 
broad medical background, ranging 
from training in obstetrics and 
gynecology to surgery to radiology. 
At the time, radiology did not 
have departmental status, as it was 
still considered a "new service." In 
institutions across the country, the 
service most com- 
monly fell under the 
jurisdiction of the 
Surgery or Internal 
Medicine depart- 
ments. According to 
Moore (in a later 
article in the January 
1940 Washington 
University Medical 
Alumni Quarterly), 
"It is interesting that 
at the time, although 
the X ray was almost 
twenty years old, 
the press and the 
general public 
regarded the X-ray 
apparatus as a spe- 
cialized camera and 
the radiologist as a photographer; 
radiology continued to occupy 
this lowly position in medicine for 
many years before it was recognized 
as an independent field." 
Meanwhile, the X-ray Laboratory 
was definitely moving forward: 
The first high-voltage (or deep) 
X-ray therapy equipment was 
installed on March 14, 1922, and 
the first case involved treating a 
patient with recurrent cancer of 
the neck. And on February 10, 1922, 
X-ray film, instead of radiographic 
plates, was used for the first time 
for general diagnostic work. 
WE OWE IT ALL TO 
GALLBLADDER RESEARCH 
In the 1920s, Evarts Graham, 
MD, professor of surgery and 
director of the WUSM Department 
of Surgery, became interested in 
developing a test for diagnosing 
gallbladder disease. Scientific 
studies at that time showed that a 
healthy gallbladder produced 
concentrations of bile and certain 
compounds excreted almost entirely 
oAei 
in the bile. In order to visualize the 
gallbladder, a chemical compound 
had to be developed that would 
concentrate in bile, be visible by 
radiography, and be safe for the 
patients. And certain biochemical 
investigations suggested there 
FOCAL SPOT, SPRING 2006 
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might be a way to visualize the 
gallbladder by X ray—although it 
had never been done. Graham and 
Moore (WUSM's only radiologist at 
the time)—along with surgeons 
Warren Cole, MD, and Glover 
Copher, MD, began a series of 
studies in animal models. 
The researchers, working with 
a local chemical company, developed 
and tested approximately 90 com- 
pounds, 13 of which demonstrated 
the ability to concentrate in the 
gallbladder. The first successful 
image of a canine gallbladder 
was obtained in November 1923. 
However, subsequent attempts 
to reproduce other images failed; 
mm 
>o 
Cirta 1924—first visualization of a 
human gallbladder 
the researchers discovered that 
the visualization only worked if 
the subject was fasting. The first 
cholecystogram (as the image was 
now called) of a human gallbladder 
—a student nurse volunteered 
for the study—was performed in 
February 1924. 
By 1927 cholecystography, this 
most important contribution in the 
field of diagnostic radiology, was 
universally accepted. Graham and 
Moore (who had become sole 
director of radiology after Mills 
died in 1924) were convinced that 
radiology had developed to the 
point that it merited departmental 
status at WUSM. The lab's quarters 
on the second floor of Barnes 
Hospital soon became crowded, 
and the equipment that had been 
the best available in 1914 became 
obsolete. Advancement in the field 
of radiology was so rapid and the 
demand for its services so great 
that a change had to be made. 
ESTABLISHING A 
DEPARTMENT OF RADIOLOGY 
Graham agreed that radiology 
should become a department 
separate from surgery. He 
actively began to promote radiol- 
ogy as a recognized specialty 
and to establish radiology at 
WUSM. In 1927, Graham and 
McKim Marriott, MD, then Dean 
of WUSM, petitioned the Rocke- 
feller Foundation for support in 
establishing a Department of 
Radiology. The Foundation agreed 
to endow an institute of radiology, 
the first ever to be established in 
the United States. However, a 
proviso went with the endowment: 
None of the money could be used 
for construction. There was now 
money for research, but no place 
in which to conduct that research. 
B M RICKS AND ORT; I AR 
Graham and Marriott returned 
to St. Louis and approached 
Edward Mallinckrodt, Sr., head of 
Mallinckrodt Chemical Works and 
a well-known philanthropist, for 
the funds to build a facility to 
house the department. Mallinckrodt 
agreed to fund the construction. 
Mallinckrodt, Sr. died in 1928, but 
Edward Mallinckrodt, Jr. sustained 
his father's commitment by providing 
additional funds to continue con- 
struction of Mallinckrodt Institute 
of Radiology. 
The Institute's cornerstone was 
laid in October 1930. At completion, 
MIR was a nine-story building 
(eight floors plus a basement)— 
the vertical configuration of the 
building was considered unique 
for the times and still is today, as 
most radiology departments are 
arranged in a horizontal format. 
Initially most of the building was 
not occupied, but with the dra- 
matic growth of radiology in the 
1930s and '40s, the additional 
space would allow the department 
to expand. 
Routine radiography began in 
August 1931. An additional fund for 
equipment was provided by John 
Queeny, a St. Louis businessman, 
and his son Edgar. Installation of 
the new X-ray equipment began in 
July 1931, and the transfer of other 
equipment to the new facility was 
completed in September 1932. 
MIR's beginning was a combi- 
nation of Graham's and Moore's 
ingenuity, the Rockefeller 
Foundation's support, and the 
Mallinckrodt family's generosity. 
At the time, Mallinckrodt Institute 
was one of five—and the largest— 
of such institutions in the world, 
plus it was centrally located in the 
area of the hospital it served. 
MALLINCKRODT INSTITUTE OF RADIOLOGY 
RADIOLOGY AT MIR 
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When the Institute opened in 
1931, there were four radiologists 
(including Moore, the first MIR 
director) and a physicist on staff. 
Patient services were assigned as 
follows: 
• Ground floor—Radiotherapy, 
including a waiting room 
• 1st floor—General offices and 
viewing room 
• 2nd floor—General X ray 
• 3rd floor—Cystoscopy and 
surgical radiology 
• 4th floor—Fluoroscopy and 
photography 
• 5th and 6th floors—Shell space 
• 7th floor—Biological research 
• 8th floor—Film storage. 
A steady increase in clinical 
volume at Washington University 
Medical Center, expanded experi- 
ence with radiology techniques, 
and new procedures developed 
from research all contributed to the 
Institute's tremendous growth in 
the 1930s and into the '40s. In 1936, 
Jean Kieffer, a self-taught medical 
technician and radiographer at the 
Institute, developed the principles 
of body section radiography, 
involving the synchronous move- 
ment of an X-ray tube and film in 
opposite directions to image a 
small "slice" of the body. The 
resulting instrument, called a 
laminagraph, was the forerunner 
Circa 1940s—doctors 
Wendell Scott (left) 
and Sherwood Moore 
in a fourth-floor 
radiology suite. 
of computed 
tomography 
and magnetic 
resonance 
imaging. 
Around that 
same time, 
Wendell Scott, 
MD, the first 
assistant of 
radiology at MIR, developed 
roentgen kymography, a method 
of recording the movements of 
various organs and structures on 
a single X-ray film. In July 1937, 
the first three-year program for the 
training of physicians to become 
radiologists eligible for certification 
by the American Board of Radiology 
was established; William Burton, 
MD, and Allan Phillips, MD, 
were the first trainees at MIR. 
In 1938, University and MIR 
leaders agreed that applying 
nuclear physics (a new and rapidly 
advancing field) to the areas of 
medicine and biology held great 
promise for radiology research. A 
cyclotron, to be designed and built 
specifically for medical use, was 
funded in part by a grant from the 
Rockefeller Foundation. Due to 
insufficient space at the Medical 
Center, the cyclotron was 
constructed and housed on the 
University's main campus (known 
as the Hilltop Campus). 
9he /940J 
Isotopes of cobalt, iron, and 
phosphorous, produced by the 
cyclotron, were available for med- 
ical use at WUSM in March 1942. 
In 1943, at the request of the United 
States government, the cyclotron 
was used during World War II 
to produce plutonium for the 
Manhattan Project. 
In 1945, Martin Kamen, a 
research chemist and a codiscov- 
erer of carbon 14, joined the MIR 
staff. He developed a laboratory of 
basic research in the field of inter- 
mediary metabolism. The United 
States War Department released a 
small amount of radioactive carbon 
14 to the Medical Center (and to 
the Institute) for cancer research. 
A Cobalt 60 unit, used to 
deliver higher energy radiation 
therapy, was installed on the 
Institute's ground floor in 1948. 
Radiologists collaborated with 
physicians from the Department 
of Obstetrics/Gynecology in using 
Cobalt 60 to treat patients with 
gynecological cancer. 
Realizing the need to improve 
angiographic techniques, Scott 
envisioned capturing a series of 
images in rapid sequence as con- 
trast media circulated through 
organs or vessels. In 1949, he 
developed the rapidograph, which 
greatly improved angiography, by 
adapting a Fairchild A-5 aerial 
camera used during World War II. 
In July 1949, Moore retired as 
director of the Institute and was 
succeeded by Hugh Wilson, MD, 
a WUSM graduate. Wilson, an MIR 
staff member from 1931 to 1934, 
was chairman of Yale University's 
Department of Radiology when he 
was asked to become director 
of Mallinckrodt Institute. Shortly 
after his arrival, Wilson defined his 
goals for the Institute: establish 
radiological subspecialties and 
emphasize education. 
Editor's note: The second install- 
ment ofMIR's history will focus 
on the 1950s, '60s, and '70s— 
decades that involved ground- 
breaking developments in 
radiology technology as well as 
rapid expansion at the Medical 
Center and at MIR. (Special thanks 
to Sue Day, in MIR's abdominal 
imaging section, for sharing the 
Merenda manuscript.) 
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The Metabolism of the 
Diabetic Heart: 
Not Just a Bystander in Heart Disease 
by Candace O'Connor 
More patients with diabetes mellitus die from cardiovas- 
cular disease than from any other cause. And the number of 
diabetic patients in the United States is rising rapidly: from 
14 million in 2000 to a projected 18 million by 2010. Clearly, 
finding the underlying reasons for heart problems in these 
patients is critically important—and for years scientists have 
been studying various aspects of this problem, including the 
role played by atherosclerosis, hypertension, and vascular 
changes in coronary artery disease. 
"But physicians and researchers 
have long ignored the metabolism 
of the heart," says Robert Gropler, 
MD, director of Mallinckrodt 
Institute of Radiology's (MIR's) 
Cardiovascular Imaging Laboratory. 
"They have looked at it as a kind 
of innocent bystander in what 
happens—not really much of a 
contributor to what goes on. 
But we're learning that it is 
much more than just a 
bystander; in fact, the heart's 
metabolism may well be 
one of the primary mecha- 
nisms by which various 
disease processes, in this 
case diabetes, have a 
detrimental effect on 
heart function." 
Gropler and his colleagues 
in the Cardiovascular Imaging 
Laboratory—most notably, Pilar 
Herrero, MS, a research associate 
professor of radiology—and 
key collaborators from other 
departments—particularly 
endocrinologist Janet McGill, 
MD, of the Department of Internal 
Medicine—have been investigating 
this problem. Recently, they 
published two papers in the 
Journal of the American College 
of Cardiology: the first, in July 
2005, demonstrating that high 
glucose levels impair blood flow to 
the diabetic heart; and the second, 
•Ex 
:f,: 
[in February 2006, examining the 
| impact of increased myocardial 
fatty acid metabolism on patients 
with type 1 diabetes and, specifi- 
i cally, on their cardiac function. 
This work was funded by the 
'- National Institutes of Health in the 
form of a program project grant 
from the National Heart, Lung, 
and Blood Institute; Michael 
Welch, PhD, codirector of MIR's 
Division of Radiological Sciences, 
is principal investigator. 
The investigators began their 
work within a research context 
particularly conducive to this kind 
of project. At Washington Univer- 
sity in St. Louis School of Medicine, 
scientists have long engaged in a 
major effort to better understand 
diabetes: its basic molecular 
biology, how it affects patients, 
and evaluating new treatment 
strategies. Some University-based 
research groups also have focused 
on studying how the heart's 
increased fat metabolism may 
be detrimental. 
Symptoms of Diabetes 
lecent studies indicate that early 
ietection of diabetes symptoms and 
rly treatment can decrease the chance 
' developing complications associated 
vith diabetes. 
1
 Frequent urination 
ixcessive thirst 
' Extreme hunger 
Unusual weight loss 
Increased fatigue 
1
 Irritability 
'Blurred vision. 
At MIR, Gropler 
and his group also 
had a rich history 
of positron-emission 
tomography (PET) 
expertise to draw 
upon [PET was 
developed at MIR in 
the 1970s.], includ- 
ing the ability to 
make novel radio- 
pharmaceuticals as 
carbon-11 palmitate 
and carbon-11 glucose. 
In addition, work 
led by Herrero 
pioneered the primary 
imaging approach 
that allows the 
researchers to use 
"...researchers have long ignored 
the metabolism of the heart..." 
PET and these radio- 
pharmaceuticals to 
quantify cardiac fat and 
glucose metabolism. 
"Our ability to 
conduct these in-depth 
measurements of 
myocardial substrate 
metabolism that 
aren't being done in 
other labs worldwide 
is really a tribute to 
the quality of the 
imaging infrastructure 
at MIR and to the 
whole PET enter- 
prise," says Gropler, 
professor of radiology, 
of medicine, and of 
biomedical engineer- 
ing. "Because of this 
unique depth and breadth, we can 
do these highly complex studies 
that permit a comprehensive 
and noninvasive assessment of 
myocardial substrate use." 
(Above) Theresa Butler, RN, research nurse coordinator, 
prepares the study volunteer for PET scanning. 
(Below) Butler is injecting C-l 1 acetate into an IV in 
the volunteer's left arm. C-l 1 acetate measures the 
heart's oxygen usage. 
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Types of Diabetes 
Type 1 —previously called 
insulin-dependent diabetes mel- 
litus or juvenile-onset diabetes. 
Develops when the body's 
immune system destroys pancre- 
atic beta cells, the body's only 
cells that produce the hormone 
insulin that regulates blood 
glucose. Patients with type 1 
diabetes receive insulin via 
injection or a pump. 
Type 2—previously called 
noninsulin-dependent diabetes 
mellitus or adult-onset diabetes. 
Accounts for approximately 
90 percent to 95 percent of all 
diagnosed cases of diabetes. 
Associated with older age, obesity, 
family history of diabetes, history 
of gestational diabetes, impaired 
glucose metabolism, physical 
inactivity, and race/ethnicity. 
Gestational diabetes—a form 
of glucose intolerance diagnosed 
in some women during preg- 
nancy. More common among 
obese women and those with 
a family history of diabetes. 
During pregnancy, gestational 
diabetes requires treatment to 
normalize maternal blood glu- 
cose levels to avoid complica- 
tions to the infant. 
Other types—result from 
specific conditions such as 
maturity-onset diabetes of youth, 
surgery, drugs, malnutrition, 
infections, and other illnesses. 
Such types of diabetes account 
for 1 percent to 5 percent 
of all diagnosed cases. 
Excerpted from the American 
Diabetes Association Web site 
at wwwxliabetes.org. 
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Gropler and his colleagues 
decided to build on the University's 
existing research base by looking 
at heart metabolism in diabetic 
patients. They also had another 
reason to target this issue: a wealth 
of data in animal models showing   - 
that the diabetic heart becomes 
overly dependent on fats and loses 
its ability to process a range of 
other substrates, such as glucose 
or lactate.   Unfortunately, this 
flexibility is the key to heart health. 
In fact, he adds, the ratio of fat 
usage by the diabetic heart changes 
dramatically. Ordinarily, it might 
represent 60 percent or 70 percent 
of the various energy substrates, 
with another 20 percent of glucose, 
15 percent of lactate, and a tiny 
amount of amino acid usage— 
but now 90 percent of the heart's 
substrate usage is fat. Other 
researchers at the University 
currently are performing novel basic 
research into why this change occurs. 
diabetic heart becomes 
overly dependent on fats... 
Why does this shift to fatty acid 
dependency occur? It is caused by 
what is happening elsewhere in the 
diabetic body. Because of their 
insulin resistance, diabetic patients 
develop very high levels of fat in 
the blood, either in the form of free 
fatty acids or triglycerides. Day 
after day, those fats travel through 
the blood to the heart. 
"And the heart is like the family 
dog," says Gropler. "It will eat 
whatever is put in front of it, so the 
heart starts consuming these fats at 
the expense of other substrates, 
such as glucose. That sets off 
a whole cascade of events within 
the heart muscle that changes the 
metabolism of that muscle and 
also can change other processes 
within the heart—affecting how 
it contracts, survives an 
ischemic insult, and so on." 
Gropler and his colleagues 
chose to look at another aspect of 
the problem: With most of these 
findings from animal models, 
what exactly was happening in the 
human heart? They knew that glu- 
cose metabolism was down but did 
not have much data to prove that 
fat metabolism was accelerated. 
"So that's what 
our study was based 
[on," says Gropler. 
"In diabetic hearts, 
do we see this shift 
in metabolism to 
predominantly fats, 
and could we begin 
to understand why 
that was occurring, 
even obtaining 
data to suggest 
that it was this fat 
delivery problem?" 
They decided to 
begin with a proof- 
of-concept study, 
comparing a group 
of young, healthy 
type-1 diabetic 
patients to age- 
matched and 
gender-matched 
volunteers without 
diabetes. The 
researchers ensured 
that glucose and 
insulin levels were similar between 
the two groups and then used PET 
to measure the blood flow, oxygen 
usage, glucose metabolism, 
and fatty acid metabolism in all 
of the study participants. 
"We found that the 
diabetic participants 
were burning three 
times as much fat as the 
ones without diabetes, 
and the data suggested 
that this was being 
driven primarily by 
the increased fat 
delivery to the 
heart muscle," 
says Gropler. 
"-:;■'^i 
Robert Gropler, M.D. 
"This increased delivery caused 
the heart to rev up its oxidative 
machinery to burn the fat. A 
byproduct of that increased fat 
burning, known as reactive oxygen 
species, may ulti- 
mately damage the 
machinery, leading 
to a decline in the 
capacity of the heart 
to burn the fats it 
takes up. As a 
consequence, fats 
accumulate in the 
heart, initiating 
a process called 
'lipotoxicity.'" 
As a concept, 
lipotoxicity is 
relatively new and 
currently is being investigated as to 
its relevancy in humans, though its 
impact has already been shown by 
Washington University investiga- 
tors in numerous animal models. 
Robert Gropler, MD, and Piiar Herrero, MS, research 
associate professor of radiology, are coauthors of the 
paper "Increased myocardial fatty acid metabolism in 
patients with type 1 diabetes mellitus." 
(Left) Janet McGill, MD. 
But Gropler and his team believe 
that, over a period of time, the 
increased fat delivery will have 
detrimental effects on the heart 
muscle, reducing the glucose 
uptake in the heart and affecting 
processes related to cardiac 
function as well as cell survival. 
How long it takes for this kind 
of effect to occur is unclear. "What 
we can say, based on a few initial 
studies, is that a person only has to 
ingest fats and, thus, have high fat 
delivery to the heart for just a few 
weeks to see a reduction in its 
energy production," says Gropler. 
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Control-Palmitate 
Fatty Acid Uptake:    145 nmol/g/min 
Fatty Acid Oxidation: 140 nmol/g/min 
Myocordial images of C-l 1 palmitate uptake in a normal 
control and a diabetic patient. Highest uptake is white 
and lowest uptake is black. C-l 1 palmitate uptake and, 
thus, fatty acid uptake is higher in the diabetic patient. 
Measurements of fatty add uptake and oxidation, as 
measured by mathematical modeling of the PET data 
demonstrate quantitatively higher fatty acid uptake and 
oxidation in the diabetic heart. 
A key clinical question is how 
to prevent these cardiac conse- 
quences altogether—and that 
question will guide the next phase 
of the group's work. The working 
hypothesis is that a major driver of 
this problem is the level of insulin 
resistance in diabetic patients: 
Improving their insulin sensitivity 
may reduce the fat release by adi- 
pose tissue, decreasing the fat level 
Diabetic-Palmitate 
Fatty Acid Uptake: 201 nmol/g/min 
Fatty Acid Oxidation: 179 nmol/g/min 
in the blood and its delivery to the 
heart. If so, lifestyle changes—such 
as weight loss, exercise, and agents 
to increase insulin resistance— 
may be the answer. 
To prove this hypothesis, the 
group has currently undertaken a 
comprehensive study involving 
volunteers with type 2 diabetes, 
who are screened to exclude those 
with sub-clinical cardovascular dis- 
ease and then randomly assigned to 
several groups: one group will be 
treated with conventional agents 
to keep their blood sugar within 
normal range, and other groups will 
be treated with agents designed to 
lower the fat delivery to the heart. 
Confirmation of reduced fat delivery 
to the heart will be achieved by 
performing stable isotopic measure- 
ments of fat release by adipose 
tissue—aided by nutrition expert 
Samuel Klein, MD, of the 
Department of Internal 
Medicine. Combining 
these measurements 
with PET studies of 
heart metabolism and 
echocardiographic 
studies of cardiac 
function will permit a 
comprehensive under- 
standing of how 
decreasing fat release 
by the body's fat stores 
may ultimately improve 
cardiac metabolism and 
function in patients 
with diabetes. 
"This study will 
define for us whether, 
in fact, fat delivery is 
playing a role in cardiac 
disease that afflicts diabetic 
patients and why it is playing that 
role," says Gropler. "The study also 
will provide guidance as to whether 
we should begin altering our thera- 
peutic strategies to include paying 
greater attention to the level of 
fats in the blood and not just the 
level of glucose." 
At the same time, the Cardio- 
vascular Imaging Laboratory is 
looking at other related problems. 
Do obesity and insulin resistance 
contribute to these same alterations 
in metabolism? What role does 
aging or gender play in substrate 
metabolism? 
"We are excited about this 
work," he says. "The beauty of 
this technology and the strength 
of these studies are that they 
provide concrete information as 
to what is happening in the 
diabetic heart." EH 
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Virtual 
Colonoscopy 
a Lifesaving Technology 
by Anne Kessen Lowell 
7B  The dreaded colonoscopy has long been a staple of 
the late-night comedy circuit—to wit the popular 
lead-in, "I'd rather have a colonoscopy than...." 
But the descent of popular culture into prurient and 
scatological "humor"—via television, music, and Howard 
Stern—has not led the American public to talk openly about 
problems with, well, our bottoms. That, say health experts, 
is keeping millions of Americans from getting the screening 
test they need and putting them at risk for colon cancer. 
Granted, a colonoscopy is not a walk in the park; it is a pain 
the (you fill in the blanks). But the procedure has the power 
to prevent the second most deadly cancer in the United States. 
Health professionals and advocates are fighting to increase 
awareness about colon cancer and the need for screening. And 
clinical researchers are evaluating new noninvasive technologies 
to make colon screening easier, faster, and more comfortable. 
Virtual Colonoscopy: 
a Lifesaving Technology 
A\     I Mallinckrodl Institute 
MM      of Radiology (MIR), 
B ■       researchers are 
^^^^^^^     some extraordinary 
^7 ^A   volunteers in 
promising study 
involving computed tomography 
(CT) colonoscopy, or "virtual" 
colonoscopy. More than 150 
volunteers to date have undergone 
not one but two colon screening 
procedures in one day. Christine 
Menias, MD, assistant professor of 
radiology at Washington University 
in St. Louis School of Medicine and 
a staff physician at Barnes-Jewish 
Hospital, is leading the effort at 
MIR, one of 15 sites across the 
country involved in the National 
CT Colonography Trial. The trial 
is funded by the National Cancer 
Institute (NCI) and coordinated by 
the American College of Radiology 
Imaging Network (ACRIN); 
nationally 2,300 volunteers will 
participate. CT colonography uses 
noninvasive technology to look 
inside the colon. The test can be 
completed more quickly and 
comfortably than optical 
colonoscopy, the most effective 
screening test in use today. The 
purpose of the ACRIN trial is to 
determine whether CT colonogra- 
phy is as effective as colonoscopy 
in detecting polyps (the precursors 
to cancer) and in detecting growths 
that have already become cancers. 
"We have to do everything 
we can to increase preventive 
screening," says Menias. "I see two 
nonresectable colon cancer cases 
every week at Barnes-Jewish 
Hospital alone. This is simply 
unacceptable. We must continue 
to develop technologies that will 
put patients at ease while providing 
the same level of diagnostic accu- 
racy we are accustomed to having." 
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Colon Cancer Is 
Preventable 
Cancers of the colon and 
rectum are ranked as the second 
deadliest cancer, with more than 
55,000 American deaths each year. 
(According to the Annual Report 
to the Nation on the Status of 
Cancer, published in 2005 in the 
Journal of the National Cancer 
Institute, lung cancer is the leading 
cause of deaths in men and 
women—more than 160,000 deaths 
annually.) About 147,000 Americans 
were diagnosed with colon cancer 
in 2005, and treatment costs in the 
United States annually exceed 
eight billion dollars. But colon 
cancer (the term is commonly used 
to include cancer of the colon and 
rectum) also is the most pre- 
ventable cancer. Controlling the 
usual suspects—obesity, poor diet, 
lack of exercise, and smoking— 
can reduce individual risk, but 
the most effective weapon against 
colon cancer is early screening 
and detection. 
'm* 
Colon cancer is stealthy, 
taking years to become a 
threat. It can be prevented if 
polyps, the precursor to can- 
cerous tumors, are found and 
removed early. Polyps are 
growths on the lining of the 
colon that can mutate and grow 
into a cancerous tumor mass. 
Polyps are imperceptible with- 
out a view inside the colon; 
they do not cause symptoms. 
By the time one notices blood 
in the fecal stool or changes 
in bowel movements, or experi- 
ences pain, colon cancer may 
have spread outside the intestine 
to other organs. At that point, 
the disease may be untreatable. 
One of the biggest risk 
factors for colon cancer is age, 
with 90 percent of cancers 
appearing in people age 50 and 
older. The disease hits the African- 
American community especially 
hard; the colon cancer death rate 
among African-Americans is 40 
percent higher than for whites. 
Inadequate screening may be a 
primary reason for this disparity. 
Studies have estimated that only 30 
percent to 50 percent of Americans 
over age 50—perhaps 42 million in 
all—have been screened for colon 
cancer. By comparison, 72 percent 
of women over age 50 have 
received a mammogram, the 
screening test for breast cancer. 
A CT look inside the colon. 
\    A 
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Obstacles to Screening 
Embarrassment and trepidation 
contribute to low colon cancer- 
screening rates. "Paradoxically, 
people don't get screened because 
they think we'll find something. 
And, let's face it, people don't like to 
talk about colons," explains Menias. 
But awareness and cost also 
are culprits. Celebrity activism has 
been effective in raising awareness, 
notably by morning talk-show host 
Katie Couric, who underwent a 
colonoscopy before a national 
television audience during a Today 
Show segment in 2000. Former 
major league baseball player Eric 
Davis, a St. Louis Cardinal in the 
1999-2000 season, overcame 
colon cancer and is a determined 
advocate for screening. 
Lack of insurance coverage 
prevents many people from being 
screened. It was only in 2001 that 
Medicare approved reimbursement 
for screening colonoscopy for 
people of "average" risk—that is, 
beneficiaries age 50 and older. 
Prior to that change, only fecal 
occult blood tests (known as FOBT) 
and sigmoidoscopy were covered, 
with colonoscopy reserved for those 
patients considered at high risk. In 
many states, private insurance may 
not cover the procedure. In 2006, 
the National Colorectal Cancer 
Research Alliance (known as 
NCCRA and founded by Couric) 
rated state-mandated private 
insurance coverage for screening 
colonoscopies. Missouri and 
Illinois are among 14 states, along 
"There is not enough awareness\ 
...about the importance of screening, 
especially for people at high risk." 
Menias stresses that much 
more should be done, especially in 
the area of informing primary care 
physicians. "There is not enough 
awareness among primary care 
physicians about the importance 
of screening, especially for people 
at high risk. It is a tragedy to see 
patients in the emergency depart- 
ment with urgent symptoms 
indicating colon cancer. We need 
to give this disease the same priority 
as other cancer screenings that 
are now considered as routine." 
with the District of Columbia, that 
received an "A" grade for basing 
their coverage requirements on the 
latest medical recommendations— 
that is, for colonoscopy. A-rated 
states go one step farther by refer- 
encing American Cancer Society 
guidelines, allowing for coverage of 
future advances in screening, such 
as CT colonography. Twenty-eight 
states were graded "F" by the 
NCCRA, indicating they have no 
legislation requiring any type of 
colon cancer screening. [At press 
time, according to the American 
Cancer Society, a bill before the 
United States Senate (Senate Bill 
1955) may override state regula- 
tions and allow privateplrwi^to 
exclude screening tests such as* 
colonoscopies and mammograms.f 
Common symptom 
of colorectal cancer 
• Change in bowel habits 
• Diarrhea, constipation, or feeling 
that the bowel does not empty 
completely 
• Blood (either bright red or very 
dark) in the fecal stool 
• Fecal stools that are narrower 
than usual 
• General abdominal discomfort 
(frequent gas pains, bloating, 
fullness, and/or cramps) 
• Weight loss with no known reason 
• Constant fatigue 
• Nausea and vomiting. 
These symptoms are not unique 
to colorectal cancer and may be 
caused by other health issues. 
If you experience any of the above 
problems, contact your physician 
for a proper diagnosis. 
Information provided by the 
National Cancer Institute. 
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Ruth Holdener (seated) and Christine Menias, MD, 
review images obtained by a 64-detector CT scanner 
that provides superior resolution and sharp images, 
plus its surprising speed is a plus for patients. 
"A colbnoscopy requires about 
forty-five minutes for the procedure 
and up to an hour for recovery," 
she notes. "Typically a sedative is 
given, so the patient must have 
someone drive them home, and the 
patient likely will miss an entire 
day of work. CT colonography is a 
test with about five minutes of dis- 
comfort and a half hour of recov- 
ery. The patient couldfreturn to 
work after the test." 
The promise of CT colonography 
to match or to better colonoscopy 
as a diagnostic tool was first 
demonstrated in 2003 by Perry 
Pickhardt, MD, a 1999 graduate 
of the MIR diagnostic radiology 
residency training program and 
now an associate professor in the 
Department of Radiology at the 
University of Wisconsin-Madison 
Medical School. In a study of 1,233 
asymptomatic adults, Pickhardt 
atest with about five minutes of 
discomfort and a half hour of recovery. 
The patient could return to work 
Testing Day 
Colonoscopy is the screening 
tool most favored by physicians. 
It has the highest accuracy rate in 
detecting polyps and allows for the 
removal of polyps during the pro- 
cedure. But a colonoscopy can be 
uncomfortable, may require hours 
of recovery, and carries some risk. 
Currently, technology cannot help 
patients avoid the most unpleasant 
part of either optical colonoscopy 
or CT colonography: the "prep." 
after the test." 
For both tests the colon must be 
vigorously cleansed: a feat accom- 
plished by the patient consuming 
up to one gallon of a laxative fluid 
the night before the procedure. 
Menias believes that the greater 
convenience of CT colonography 
on the day of the procedure will 
convince more people to come in 
for the screening test. 
achieved polyp detection rates in 
line with optical colonoscopy, even 
in polyps as small as 6 millimeters 
in diameter. Intrigued by these 
results, NCI decided to support a 
multicenter trial comparing the 
two procedures. 
Ruth Holdener is a research 
assistant at MIR who is responsible 
for recruiting volunteers for the CT 
colonoscopy study. Holdener culls 
the list of people scheduled for 
colonoscopy for those eligible for 
the trial. "Once I explain the objec- 
tives of the study, people are usually 
16 MALLINCKRODT INSTITUTE OFRADIOLOG) 
)Ut 
ure 
.s 
the 
i a 
is- 
Dhy 
>y 
33 
en 
willing to volunteer. When the trial 
first started, we ran one TV ad and 
received about two hundred and 
fifty telephone calls. We've already 
exceeded our target enrollment 
for the study." 
In order to obtain comparative 
data, each volunteer must undergo 
both the CT colonography and 
optical colonoscopy. Fortunately 
only a single prep is required the 
day before the procedures. For CT 
colonography, patients also must 
consume a small amount of barium 
and another liquid called Gastro- 
view®, which coats (or "tags") any 
remaining fecal stool to distinguish 
it on the CT image from polyps or 
cancerous growths. No sedation is 
given. As the patient lies on the 
examination table, a small quantity 
of carbon dioxide (C02) is intro- 
duced into the colon, scans are 
taken in both the supine and prone 
positions. "Most patients experience 
about four to five minutes of dis- 
comfort," explains Menias. "The 
carbon dioxide is absorbed or 
expelled within half an hour." 
After recovery from the 
colonography, volunteers proceed 
to the colonoscopy suite for the 
second procedure. Later, they are 
asked to compare their experience 
with each test, to recount how 
much time was required to recover 
from the colonoscopy, and the time 
spent by others to provide trans- 
portation and at-home care. The CT 
colonography is provided free-of- 
charge; the colonoscopy is charged 
to the patient's insurance provider. 
Future Advances 
Menias looks forward to the 
conclusion of the trial and the 
release of the data. CT colonography 
does have some advantages over 
colonoscopy; it can measure polyps 
with greater precision and allows 
radiologists to quickly scan other 
abdominal organs. So far in the 
MIR trial, CT colonography has 
detected kidney stones, gallstones, 
and an adrenal cancer in volunteers. 
"If we continue to perfect soft- 
ware technology and radiologist 
training, CT colonography could 
be an excellent complement to 
colonoscopy," says Menias. 
"Everyone could be screened when 
they should be, faster and with less 
discomfort. No one would have to 
miss a day's work to get this impor- 
tant test. If polyps are detected in 
CT colonography, the patient will 
go straight to colonoscopy to have 
the polyps removed. And one day 
we may be testing a low-prep or no- 
prep CT colonography, using 
advanced fecal stool tagging 
methodologies." 
Resources 
For information about MIR's 
CT Colonography Trial, call 
(314) 747-2034 or send an 
e-mail to holdenerr@mir.wustl.edu. 
Call St. Louis Connect Care at 
(314) 879-6392 for information 
about free fecal occult blood test 
screening. 
For colon and rectum cancer informa- 
tion online, visit these Web sites: 
• American Cancer Society: 
www.cancer.org 
• National Colorectal Cancer 
Research Alliance: www.nccra.org 
• National Cancer Institute: 
www.cancer.gov 
Menias concedes this could be 
years away and emphasizes that 
raising awareness now is impera- 
tive. People at high risk for colon 
cancer and those over age 50 
should talk to their doctor now 
about a screening test. 
Everyone else should plan 
to give themselves a lifesaver 
for their fiftieth birthday: a colon 
cancer-screening test. EM 
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Embolization 
An Alternative 
to Hysterectomy 
for Treating Fibroids 
In the United States, 
an estimated 5.5 million 
women suffer with symptomatic 
uterine fibroids. These are benign 
tumors, or myomas, and can 
cause significant problems that 
may severely impact women's health. 
by Mary Jo Blackwood, RJV, MPH, CHES 
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hey often compress the 
bladder, causing urinary 
quency, urgency, and 
ontinence.   Or they 
y create bowel problems 
or pain during intercourse. Over 
eighty-five percent of the time, 
symptoms include excessively 
heavy, painful [menstrual] periods; 
some patients can become severely 
anemic. Symptomatic fibroids can 
range in size from several millime- 
ters to larger than [the equivalent 
of] a pregnancy," says David 
Hovsepian, MD, an interventional 
radiologist with Mallinckrodt 
Institute of Radiology and a staff 
physician at Barnes-Jewish Hospital. 
Fibroids usually will shrink on 
their own once menopause has 
begun, because of the decrease in 
circulating estrogen. But many 
women experience symptoms 
long before that point. Treatment 
options include hormonal therapies 
or surgery, either myomectomy 
(excision of individual fibroids) 
or, more commonly, hysterectomy 
(surgical removal of the entire 
uterus). An option preferred by 
many women is one of Hovsepian's 
specialties—uterine fibroid 
embolization (UFE). 
How UFE Works 
UFE (sometimes referred to 
as uterine artery embolization or 
UAE) takes about an hour and only 
requires intravenous sedation and 
local anesthesia. Similar to a heart 
catheterization, a small plastic tube 
(catheter) is inserted first into the 
femoral artery in the groin, which 
is then threaded into the uterine 
arteries where tiny embolic parti- 
cles—about the size of grains of 
sand—are released. Propelled by 
blood flow, the particles become 
lodged in the tiny branches that 
(Left) Pre-UFE: Here, the fibroids fill the uterus. The catheter is seen an the left. 
(Right) Post-UFE: The fibroids have diminished because their blood supply was blocked by the embolic particles fed 
through the catheter. 
feed the uterus and fibroids and 
block their blood supply. The 
uterus is able to draw on other 
vessels to sustain itself and is 
totally recovered within a few 
days. Fibroids have no such 
capacity and quickly starve to 
death. On average, fibroids will 
shrink to 50 percent or 60 percent 
of their volume and become soft 
and spongy, relieving pressure on 
adjacent organs. 
Interestingly, says Hovsepian, 
UFE as a primary treatment for 
fibroids was discovered by acci- 
dent in France in the early 1990s. 
A severe nationwide blood supply 
shortage prompted surgeons to 
request that a patient have uterine 
embolization a few weeks before 
myomectomy to help reduce blood 
loss during what can be very 
bloody surgery. A significant 
number of those women who had 
undergone embolization later 
refused myomectomy because 
their symptoms were improving. 
Before the '90s, UFE commonly 
was performed by interventional 
radiologists for postpartum hemor- 
rhage and for pelvic trauma—its 
use as an adjunct or stand-alone 
treatment for uterine fibroids has 
been adopted rapidly, and the 
number of procedures performed 
worldwide probably tops 100,000. 
"The symptoms, such as exces- 
sive bleeding or pelvic pressure, 
are permanently relieved approxi- 
mately eighty-five percent of the 
time. Shrinkage is often modest, 
and softening probably accounts 
for a lot of the improvement in 
symptoms. So if a woman expects 
her stomach to be flat when the 
procedure is done, she will be 
disappointed," says Hovsepian. 
"Our goal is to treat symptoms. 
This is not a cosmetic procedure. 
UFE generally turns the clock back 
about five years for women with 
fibroids and returns them to a point 
where they had not yet begun 
to experience symptoms." 
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David Hovsepian, MD. In the background are monitors connected to a digital fluoroscopy unit, which displays 
the UFE procedure in real time. 
The most common symptoms 
following UFE are cramps and 
fatigue. For that reason, Hovsepian 
admits his patients to the hospital 
overnight after UFE to optimize 
their comfort. "Some centers allow 
patients to go home the same day, 
but recovery can sometimes be 
more than oral medications can 
handle. A significant percentage of 
women, perhaps as high as fifteen 
percent, will return to the hospital 
because of inadequate pain control. 
That is unacceptably high for me," 
says Hovsepian. 
Following UFE, cramping is 
usually intense for four hours to six 
hours, tapering off over the next 
day or so. Patients may take pain- 
relief medication for a few days 
and are given an anti-inflammatory 
medication for a week. Most 
women recuperate within a few 
days but often are surprised by the 
degree of fatigue as the body 
musters resources to heal itself. 
According to Hovsepian, "Some 
women go back to work within a 
week but find they 'run out of 
steam' by late afternoon for a few 
days longer. I encourage them to 
try to take two weeks off from 
work, with the option of working 
from home or returning part time 
during the second week, if they 
feel it's necessary." 
Diagnosis and 
Treatment Planning 
Hovsepian, an associate profes- 
sor of radiology at Washington 
University in St. Louis School of 
Medicine, believes the most effective 
diagnostic tool available for differ- 
ential diagnosis of fibroid symptoms 
is pelvic magnetic resonance imaging 
(MRI). "Most gynecologists are 
extremely comfortable with using 
US [ultrasound] and often have US 
labs in their offices. It has been 
difficult to convince them that the 
diagnostic information provided by 
MRI justifies the cost. My experi- 
ence, and that of other physicians, 
is that the results of a pelvic MRI 
change the treatment plan about 
fifteen percent of the time," he 
says. Hovsepian notes that MRI 
effectively has replaced the need 
for a physical examination and shows 
not only the uterus and its internal 
architecture but all of the other 
pelvic organs to best advantage. 
"MRI can demonstrate uterine 
anomalies and conditions such as 
endometriosis and often displays 
the ovaries when an ultrasound 
was unable to distinguish them. 
MRI often shows many more 
fibroids than the US exam revealed 
and allows the physician to corre- 
late symptoms better because the 
location, with respect to the uterus 
and adjacent organs, is clearly 
visible," says Hovsepian. "Fibroids 
don't have to be very large to cause 
severe bleeding if they arise just 
beneath the endometrial lining. 
There also are mimickers of 
fibroids that can be discerned 
by MRI, such as adenomyosis 
[endometriosis within the uterine 
wall] that can cause menstrual 
pain and heavy bleeding." 
After a patient has had a pelvic 
MRI and has been determined to be 
a candidate for UFE, she and her 
husband or partner are encouraged 
to come in for consultation. The 
clinic visit includes an informational 
video and a question-and-answer 
segment. Hovsepian then meets 
with each couple individually 
to review the MRI scan, answer 
more personal questions, and 
address issues relevant to each 
patient's situation. 
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(Top) MRI scan of uterine tumor taken prior to UFE. 
(Bottom) MRI scan taken after UFE. 
"Before we started doing 
the group seminars, consultations 
were taking longer and longer— 
sometimes hours—and I was 
largely repeating myself. The video 
allows me to cover a lot of informa- 
tion without accidentally leaving 
things out," he says. "The time I then 
spend with patients, both in the 
group Q-and-A session and individ- 
ually, is put to much better use. 
Many of the attendees already have 
been using the Internet, 'Googled' 
me, and come in with a list of ques- 
tions. Now I can usually make sure 
all of their questions are answered." 
Track Record 
Gynecologists perform approx- 
imately 250,000 surgeries for 
fibroids each year nationwide. 
According to a Wall Street Journal 
article (August 24, 2004), most 
women with symptomatic fibroids 
are not informed by their gynecolo- 
gists that UFE is an option. The 
article postulated why this alterna- 
. tive to hysterectomy often goes 
unmentioned—namely, money. 
Gynecologists have not 
been trained to perform 
UFE, which is being per- 
formed and promoted by 
interventional radiologists, so 
the potential loss in income 
for gynecologists has been 
estimated to be as high as 
$400 million. 
The article went on to 
note that some gynecologists 
view UFE as an experimental 
procedure, although this 
view is changing. However, 
many women still have to 
mention UFE when discussing 
fibroid treatment options with their 
gynecologist, and many patients 
going in for an office visit are better 
informed about UFE than are 
their doctors—thanks in part to 
the Internet. 
Hovsepian is happy to hear 
that UFE is increasingly mentioned 
as an alternative but is disappointed 
at how often misinformation 
is passed along to patients. "Many 
times, women might have been 
informed about UFE but were 
quickly told that it was not 
an option for them because there 
were too many fibroids or the 
fibroids were too large—when 
that was not the case at all. I am 
always grateful when I hear a 
woman say that her doctor told her 
that he didn't know much about 
the procedure and to contact us to 
learn more about it," he says. "At 
the Washington University Com- 
prehensive Fibroid Center, we have 
treated approximately four hundred 
women since we started doing 
UFE in 1998. Fortunately, UFE has 
become widely accepted by insur- 
ance carriers and health plans, 
including Medicare and Medicaid." 
Facts & Figures 
• An estimated 40 percent of all women 
have uterine fibroids. While most women 
have no symptoms, one in four eventually 
has symptoms severe enough to require 
treatment. 
• African-American women are two times to 
three times more likely to have symptomatic 
uterine fibroids, typically at a younger age 
than the rest of the population of women 
with uterine fibroids. 
• Asian women have a lower incidence of 
symptomatic uterine fibroids. 
• Average age range in which fibroids 
become symptomatic is 35 years to 50 
years. 
• Obesity is associated with the presence of 
uterine fibroids. 
• High consumption of red meat and ham 
has been associated with the presence of 
uterine fibroids. 
• Research has shown some reduced inci- 
dence of uterine fibroids in women whose 
diet was high in green vegetables, fruit, 
and fish. 
• Changes in a woman's hormone levels 
may impact fibroid growth. 
• Fibroids grow rapidly during pregnancy 
when hormone levels are elevated and 
tend to shrink after menopause when 
hormone levels are decreased. 
Information excerpted from the National 
Uterine Fibroids Foundation Web site at 
www. nuff. org/health .htm. 
Pricewise, though, UFE has 
no advantage over hysterectomy 
or myomectomy, he adds. "The real 
savings come after the procedure. 
Patients recover quickly and return 
to work earlier, and there is no inci- 
sion to heal. Patients' quality of life 
is improved because they are back 
to their usual activities sooner. That's 
a savings for employers, patients, 
and insurers," says Hovsepian. 
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Ernbolization 
A female flight attendant cited 
in the Wall Street Journal article 
was recommended to have a hys- 
terectomy for her fibroids but then 
found out about UFE and had it 
performed. She was back at work 
in a week, as compared to the usual 
four weeks to eight weeks she would 
have been off the job after surgery. 
National statistics show that 
10 percent to 15 percent of women 
who have UFE will need a foUow-up 
procedure, usually some years 
later, because of recurrent symp- 
toms from fibroids that either did 
not fully succumb or from growth 
of new fibroids. "UFE kills the 
majority of existing fibroids, 
but these women have already 
demonstrated that their uterus has 
a propensity to make fibroids. A 
significant number of women we 
have treated with UFE already have 
had one or more myomectomies in 
the past," explains Hovsepian. 
According to Hovsepian, 
myomectomy is still considered the 
treatment of choice for women who 
want to conceive; although, if there 
are too many fibroids or if the fibroids 
are too large, myomectomy surgery 
can be challenging and a hysterec- 
tomy may be necessary because the 
surgical defects are too extensive to 
close. "For those women, UFE may 
Hovsepian and his interventional radiology 
colleagues perform a variety of inpatient 
and outpatient procedures for 
gynecological patients: 
• Fallopian tube recanalization 
for infertility 
• Treatment of pelvic venous congestion 
syndrome 
• Vascular access for chemotherapy 
and/or nutrition 
• Gastrostomy tube placement for nutrition 
or decompression 
• Abscess drainage 
Vena cava filter placement. 
"The procedure was so comfortable, it was almost a nonevent. 
That certainly wouldn't have been true of the hysterectomy my doctor 
wanted me to have." Linda Whiteside is talking about uterine fibroid 
ernbolization [UFE], a procedure she underwent to treat symptoms from 
large uterine fibroids. She was having painful, heavy-flow menstrual 
periods that caused anemia, and she 
experienced urinary urgency from the fibroids 
pressing on her bladder. 
"My doctor didn't give me a choice of 
not having a body part removed. I was 
afraid of the shock on my body that sudden 
menopause would cause and the length of 
time I would have to be off work, so I 
researched other options and came up with 
UFE. I had a pelvic MRI done and then sat 
down with my husband and Doctor Hov- 
sepian to go over the results. He [Hovsepian] 
showed me the fibroids [on the MRI] and 
where they were exerting pressure. He even 
pointed out a bulging disc in my spine. It 
was very interesting and comforting. I really understood what I could 
gain by having this procedure," she says. 
More importantly, the procedure accomplished what she had hoped 
it would. Her urinary symptoms were alleviated almost immediately, and 
her next menstrual period was much lighter. She received intravenous 
sedation and was connected to a "pain pump" before the procedure 
began. Whiteside experienced only some mild cramping and nausea 
afterwards. She was in the procedure room for less than an hour and 
went home after one night in the hospital. She was back at work as a 
hairdresser one week later. 
"When I told other women about this procedure, several said that 
if they had known about it, they would never have had a hysterectomy. 
Condoleezza Rice [United States Secretary of State] even chose UFE as 
treatment for her fibroids, so I'm in good company," says Whiteside. 
Linda Whiteside 
be a reasonable alternative, but 
there are no studies to date that 
prospectively have evaluated the 
issue of fertility after UFE. There 
have been reports of normal preg- 
nancies and vaginal deliveries, but 
it is too early to say whether UFE 
will be an appropriate choice 
for women desiring to preserve 
fertility," he says. 
Referrals 
Fortunately, enlightenment 
about UFE seems to be building. 
Across the country, more and more 
gynecologists are proponents of 
ernbolization because it is, in their 
opinion, an excellent treatment 
option for the all-too-common 
uterine fibroid problem. Hovsepian 
gets most of his referrals from 
gynecologists in the St. Louis area, 
and the Washington University 
Comprehensive Fibroid Center has 
the largest experience with UFE in 
the region. Approximately ten per- 
cent of Hovsepian's patients are 
self-referred and learned about the 
procedure from family, friends, 
media, or the Internet. EHH 
Editor's note: To speak to a doctor or 
nurse about UFE, call (314)362-2375 
or toll-free at 1-866-254-7237. For 
more information about UFE and the 
Washington University Comprehensive 
Fibroid Center, go online at 
www.mir.wustl.edu/patient/ 
internal.asp?NavID=563. 
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In this section, the names of employees who are full-time 
faculty or staff or who have an appointment in the 
'Department of Radiology are highlighted in boldface type. 
[EW FACULTY 
James Quirk, PhD, research 
instructor in radiology, Division 
[of Radiological Sciences. 
iRajendra Singh, PhD, 
research instructor in radiol- 
I ogy, Division of Radiological 
I Sciences. 
- Jer 
RANTS 
nnifer Gould, MD, assis- 
tant professor of radiology, 
received a three-year grant 
from the Society of Interven- 
tional Radiology Clinical 
Fellowship Research Training 
Program. The $30,000 grant 
will fund projects conducted 
by Mallinckrodt Institute inter- 
ventional radiology fellows. 
a; 
$; 
T, 
Vamsidhar Narra, MD, 
ssociate professor of radiol- 
igy, received a six-month 
grant in the amount of 
30,000 from the Barnes- 
Jewish Hospital Auxiliary for 
research on "Body MRI for 
quicker evaluation of cancer 
response to chemotherapy." 
Yuan-Chuan Tai, PhD, 
assistant professor of radiol- 
ogy, as principal investigator, 
received a two-year grant 
from The Susan G. Komen 
Breast Cancer Foundation 
for "Feasibility study of a 
high-resolution breast coil 
for PET-CT scanners." Coin- 
vestigator for the $249,349 
grant is Joseph O'Sullivan, 
PhD, professor of electrical 
and systems engineering 
and of radiology 
APPOINTMENTS/ 
ELECTIONS 
Maurizio Corbetta, MD, 
professor of neurology, of 
radiology, and of anatomy 
and neurobiology, was 
appointed chairman of the 
Program Committee for the 
12th Annual Meeting of the 
Organization for Human 
Brain Mapping, Florence, 
Italy, June 11-15. 
Michael Darcy, MD, professor 
of radiology, was elected to 
a two-year term as vice 
chairman of the Society of 
Interventional Radiology 
Foundation. He will become 
chairman of the Foundation 
in 2008. 
Colin Derdeyn, MD, associ- 
ate professor of radiology, 
was elected chairman of the 
National Institutes of Health 
Data Safety and Monitoring 
Board for the National Insti- 
tute of Neurological Disorders 
and Stroke projects— 
P50NS044378 "MR and 
Mechanical Revascularization 
of Stroke Clots Using 
Embolectomy (MR Rescue), 
and P50NS044148 "Intravas- 
cular Cooling in the Treatment 
of Stroke-Longer tPA Window 
(ICTuS-L)." He also was 
appointed to the Program 
Committee for the 31st Annual 
International Stroke Confer- 
ence, Kissimmee, Florida, 
February 16-18. 
Igor Efimov, PhD, associ- 
ate professor of biomedical 
engineering and of radiology, 
was elected chairman of the 
Cardiac Arrhythmia Mecha- 
nisms Gordon Research 
Conference to be held in 
Ventura Beach, California, 
March 18-23, 2007. He also 
was elected to the editorial 
boards of the scientific 
publications Circulation 
Research, Heart Rhythm, 
Journal of Cardiovascular 
Electrophysiology, Journal 
of Molecular and Cellular 
Cardiology, and Experimental 
Physiology. 
Jay Heiken, MD, professor 
of radiology, was appointed 
to a four-year term (2005-2009) 
on the Board of Trustees of 
the International Cancer 
Imaging Society and to a six- 
year term (2006-2012) on the 
Board of Directors of the 
Society of Gastrointestinal 
Radiologists. 
Fred Prior, PhD, research 
associate professor of radiol- 
ogy, was appointed to the 
National Alliance for Medical 
Image Computing Advisory 
Board. 
Douglas Rowland, PhD, 
research instructor of radiol- 
ogy, was elected to a second 
term as treasurer of the 
National Postdoctoral 
Association. 
Sally Schwarz, RPh, MS, 
research associate professor 
of radiology, was elected to 
a three-year term as a member 
of the Certification Board of 
Nuclear Cardiology. 
Yuan-Chuan Tai, PhD, 
assistant professor of radiology, 
was elected to a two-year 
term as a member of the 
Nuclear and Imaging Sciences 
Council of the Institute of 
Electrical and Electronic 
Engineers Nuclear and 
Plasma Sciences Society. 
Franz Wippold, MD, pro- 
fessor of radiology, was 
appointed to a one-year term 
as a member of the American 
College of Radiology Appro- 
priateness Criteria Committee. 
Pamela Woodard, MD, asso- 
ciate professor of radiology, 
was appointed to a two-year 
term as a member of the 
American Heart Association 
Program Committee for 
Annual Scientific Sessions. 
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HONORS/AWARDS 
Carolyn Anderson, PhD, 
associate professor of radiol- 
ogy and of molecular biology 
and pharmacology, organized 
Frontiers in Biological Imag- 
ing: From Cells to Humans at 
the annual meeting of the 
American Association for 
the Advancement of Science, 
St. Louis, Missouri, February 
16-20. 
Louis Gilula, MD, professor 
of radiology and of surgery, 
and coauthor Douglas Smith, 
MD, South Texas Radiology 
Group, San Antonio, received 
the award for Best Paper 
Presentation—Interventional 
Spine for "A previously 
unreported and novel 
approach to sacroplasty" 
at the American Society of 
Spine Radiology 2006 Annual 
Symposium, Las Vegas, 
Nevada, February 22-26. 
Robert Gropler, MD, 
professor of radiology, of 
medicine, and of biomedical 
engineering, served as course 
chairman of Images to Out- 
comes VI: Cardiovascular 
Imaging, Nuclear Cardiology, 
and Beyond, presented by 
the Division of Nuclear 
Medicine at Mallinckrodt 
Institute of Radiology and 
the Cardiovascular Division of 
the Department of Medicine, 
St. Louis, Missouri, April 28 
and 29. 
Fred Prior, PhD, research 
associate professor of 
radiology, served as session 
chairman and program com- 
mittee member for the Open 
Source Strategy for Multi- 
Center Image Management 
Conference, Las Vegas, 
Nevada, March 6-9. 
Biello Lecture 
On March 8, David Mankoff, MD, 
associate professor of radiology, 
University of Washington, Seattle, 
presented the Twentieth Annual 
Daniel R. Biello Memorial Lecture. 
He spoke on "Molecular imaging to 
direct cancer therapy: from early drag 
trials to clinical practice." 
Marcus Raichle, MD, 
professor of radiology, of 
neurobiology, and of neurology, 
served as a moderator for 
Frontiers in Biological Imag- 
ing: From Cells to Humans at 
the annual meeting of the 
American Association for the 
Advancement of Science, 
St. Louis, Missouri, February 
16-20. 
Lawrence Tarbox, PhD, 
research assistant professor 
of radiology, served as a 
session panelist for the Open 
Source Strategy for Multi- 
Center Image Management 
Conference, Las Vegas, 
Nevada, March 6-9. 
LECTURES 
Carolyn Anderson, PhD, 
associate professor of radiol- 
ogy and of molecular biology 
and pharmacology, presented ' I 
"Education in imaging 
sciences: the next frontier," 
at the American Association 
for the Advancement of Sci- 
ence annual meeting, St. Louis, 
Missouri, February 16-20. 
Jeffrey Brown, MD, professor 
of radiology, spoke on "MRI 
of cholangiocarcinoma and 
gallbladder cancer"; "MRI of 
the indeterminate renal 
mass"; "Body MRI: Should it 
replace CT?"; and "Successful 
investment strategies for 
physicians" at the Los Angeles | 
Radiology Society 58th 
Annual Mid Winter Confer- 
ence, Los Angeles, California, ! 
January 28 and 29. 
Maurizio Corbetta, MD, 
professor of neurology, of 
radiology, and of anatomy 
and neurobiology, presented 
"Prospective of physician 
scientists in the 21st century" | 
at the Winship Cancer 
Institute, Emory University, 
Atlanta, Georgia, April 22. 
Colin Derdeyn, MD, associ 
ate professor of radiology, of . 
neurology, and of neurologic al , 
surgery, spoke on "Acute 
stroke intervention" at 
Medical Grand Rounds, 
St. Joseph's Hospital, 
St. Charles, Missouri, 
February 7. He presented 
"Evidence based management 
of raptured intracranial 
aneurysms" at the 31st 
Annual International Strok 
Conference, Kissimmee, 
Florida, February 16-18. 
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i He spoke on "Diagnosis of 
I vasospasm" at the 9th Annual 
Joint Meeting of the American 
; Association of Neurological 
Surgeons/Congress of Neuro- 
logical Surgeons Joint Section 
on Cerebrovascular Disease 
jid American Society of 
nterventional and Therapeutic 
vfeuroradiology, Orlando, 
Florida, February 17-20. 
Igor Efimov, PhD, associate 
professor of biomedical engi- 
neering and of radiology, as 
le Doris J. W. Escher, 
M.D. Lecturer, presented 
"History and mechanisms of 
defibrillation: toward painless 
defibrillation" at Cardiology 
Grand Rounds, Albert Ein- 
stein College of Medicine, 
Montefiore Medical Center, 
[ New York City, New York, 
February 14. He presented 
"Imaging cardiac arrhyth- 
mias" to the Department of 
Biomedical Engineering, 
Saint Louis University, 
St. Louis, Missouri, February 
18. As the Astor Visiting 
Fellow, Efimov spoke on 
"Structure/function relation- 
ship of the pacemaking and 
conduction system of the 
! heart," "Towards painless 
defibrillation: virtual electrode 
theory of electrical stimulation 
of the heart," and "Imaging 
arrhythmias in 3D: the final 
frontier" at the University 
of Oxford, Oxford, England, 
March 13-17. He spoke on 
"Structure/function of the 
supraventricular pacemaking 
and conduction system of the 
rabbit heart" at Experimental 
Biology 2006: Advancing the 
Biomedical Frontier, spon- 
sored by the Federation of 
American Societies for 
Experimental Biology, 
San Francisco, California, 
April 1-5. 
Dione Farria, MD, associate 
professor of radiology, as 
keynote speaker, presented 
"Disparities in breast cancer 
screening and diagnosis" at 
2006: Genomics of Health 
Disparities Symposium, 
sponsored by the Federation 
of American Societies for 
Experimental Biology, San 
Francisco, California, April 1-5. 
David Gierada, MD, associ- 
ate professor of radiology, 
spoke on "CT evaluation of 
the chest wall" and "Lung 
cancer screening: pros and 
cons" at the Medical College 
of Wisconsin, Milwaukee, 
March 6. 
Louis Gilula, MD, professor 
of radiology and of surgery, 
spoke on "Longitudinal 
approach to sacroplasty" at 
the American Society of 
Spine Radiology 2006 Annual 
Symposium, Las Vegas, 
Nevada, February 22-26. 
As visiting professor, he 
presented "Musculoskeletal 
board review" at Oregon 
Health and Science University, 
Portland, April 10 and 14. 
Perry Grigsby, MD, profes- 
sor of radiation oncology and 
of radiology, presented 
"Clinical and translational 
science for FDG-PET in 
cervix cancer" at Grand 
Rounds, Rambam Medical 
Center, Haifa, Israel, January 
9. He presented "Brachyther- 
apy for cervical cancer" 
and "Current radiotherapy 
approach to pelvic malignan- 
cies" to the Israeli Society 
for Clinical Oncology and 
Radiation Therapy, Eilat, 
Israel, January 11-14. 
Grigsby spoke on "Technique 
and results of HDR intracavi- 
tary brachytherapy for cervical 
cancer" at the 16th Annual 
Meeting of the Association 
of Clinical Research organi- 
zations, Orlando, Florida, 
February 23-25. He spoke 
on "Cervix cancer" at 
the American Society for 
Therapeutic Radiology and 
Oncology Spring Refresher 
Course, Miami, Florida, 
March 24-26. He presented 
"Radiotherapy vs. 
chemotherapy in advanced 
staged endometrial cancer," 
"Role of radiotherapy in 
surgically staged endometrial 
cancer," and "Adjuvant radio- 
therapy in cervical cancer" at 
the 10th Biannual Congress 
of Turkish Gynecological 
Oncology Society, Antalya, 
Turkey, April 18-23. 
Robert Gropler, MD, 
professor of radiology, of 
medicine, and of biomedical 
engineering, spoke on 
"SPECT evaluation post- 
revascularization," "SPECT 
evaluation in heart failure," 
and "Read with the experts: 
SPECT and SPECT/CT" at 
Images to Outcomes VI: 
Cardiovascular Imaging, 
Nuclear Cardiology, and 
Beyond, presented by the 
Division of Nuclear Medicine 
at Mallinckrodt Institute 
of Radiology and the Cardio- 
vascular Division of the 
Department of Medicine, 
St. Louis, Missouri, 
April 28 and 29. 
Jay Heiken, MD, professor 
of radiology, presented 
"Virtual colonoscopy: update 
2006," "Acute small bowel 
obstruction: CT evaluation," 
"Principles of contrast 
administration and scan 
timing for MDCT," and 
"Abdominal aorta: aneurysm 
rupture and post-operative 
complications" at Radiology 
at the Seashore: A Practical 
Approach, sponsored by the 
University of Michigan Med- 
ical School, Naples, Florida, 
February 6-10. He presented 
"Optimizing contrast 
enhancement for MDCT" and 
participated in the Special 
Focus Session: MDCT in 
Theory and Practice at the 
European Congress of Radi- 
ology, Vienna, Austria, March 
3-7. He spoke on "Emergency 
radiology of the abdomen" 
at the 38th International 
Diagnostic Course in Davos: 
Diseases of the Abdomen and 
Pelvis, Davos, Switzerland, 
April 1-7. 
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LECTURES 
Continued from page 25 
Linda Larson-Prior, PhD, 
research associate professor 
of radiology, spoke on 
"Imaging neural function 
across scale: the promise of 
multi-modal imaging" in the 
Center for Neurodynamics, 
Department of Physics and 
Astronomy, University of 
Missouri—St. Louis, March 24. 
Jason Lewis, PhD, assis- 
tant professor of radiology, 
presented "Imaging tumor 
hypoxia: the translation of 
Cu-ATSM from the bench to 
the clinic" at St. Thomas 
Hospital, London, England, 
May 22. He spoke on 
"Metal-based PET radiophar- 
maceuticals: from pre-clinical 
development to clinical 
application" at Oxford 
University, Oxford, England, 
May 23. 
Vamsidhar Narra, MD, 
associate professor of radiology, 
spoke on "Contrast enhanced 
MRA of the abdominal aorta 
and the renal arteries," "Con- 
trast enhanced MRA run-off," 
and "MRCP: techniques and 
clinical applications" and 
presented a workstation 
demonstration at the 6th 
Annual Snowmass 2006: 
New Advances in MR and 
CT, Snowmass Village, 
Colorado, February 19-24. 
Joel Perlmutter, MD, 
professor of neurology, of 
radiology, and of physical 
therapy, spoke on "Population 
studies of dystonia" at Genetic 
Advances in Dystonia Work- 
shop, sponsored by the 
Dystonia Medical Research 
Foundation, Phoenix, 
Arizona, January 30. He 
presented "Neuroimaging 
biomarkers of P.D. progres- 
sion" at the World Parkinson 
Congress, Washington, DC, 
February 22-26. 
Fred Prior, PhD, research 
associate professor of 
radiology, presented "Image 
management for research 
and clinical trials" at the 
Open Source Strategy for 
Multi-Center Image Manage- 
ment Conference, Las Vegas, 
Nevada, March 6-9. He spoke 
on "Current status: CAB16 
imaging software" at the 
Cancer Bioinformatics Grid 
annual meeting, Washington, 
DC, April 9-11. 
Marcus Raichle, MD, 
professor of radiology, of 
neurobiology, and of neurology, 
presented the George C. 
Cotzias Lecture—"The 
visible brain: an evolving 
perspective"—at the 58th 
Annual Meeting of the Ameri- 
can Academy of Neurology, 
San Diego, California, April 1-8. 
Stuart Sagel, MD, professor 
of radiology, as visiting pro- 
fessor, presented "Interactive 
case discussions" to the 
Department of Radiology, 
University of Arizona, 
Tucson, March 30. 
Gordon Shulman, PhD, 
research associate professor 
of neurology and of radiology, 
presented "Brain systems for 
voluntary control of human 
spatial attention" to the 
Department of Psychology, 
University of Missouri— 
Columbia, March 10. 
Barry Siegel, MD, professor 
of radiology and of medicine, 
presented "The female geni- 
tourinary tract," "PET/CT of 
the breast," "Evaluation of 
melanoma," "The National 
Oncologic PET Registry," 
and "Monitoring and predict- 
ing response to therapy in 
oncology" at Nuclear Medicine 
2006: PET and PET/CT 
Imaging, Palm Beach, Aruba, 
January 22-26. He spoke on 
"PET and PET/CT artifacts 
and variants," "PET/CT in 
lung cancer," and "PET/CT 
in women's cancer" and 
participated in Interesting 
Cases: Read with the Experts 
at The Next Step in Molecular 
Imaging—PET/CT Scanner, 
sponsored by the Positron 
Emission Tomography 
Center, St. Luke's Medical 
Center, Quezon City, Phillip- 
pines, March 3. As visiting 
professor, Siegel spoke on 
"PET and PET/CT in 
women's cancers" at Robert 
Wood Johnson Hospital, 
University of Medicine and 
Dentistry of New Jersey, 
New Brunswick, March 16. 
He spoke on "Applications of 
PET and PET/CT in clinical 
oncology" and "PET and 
PET/CT in women's cancers" 
at Allegheny General Hospital, 
Pittsburgh, Pennsylvania, 
March 20. He presented 
"Clinical applications of PET 
for cancer diagnosis and 
staging," "PET in oncology: 
monitoring and predicting 
Senturia Lecture 
Cheryl Petersilge, MD, assistant 
clinical professor of radiology and 
orthopedic surgery at Case Western 
Reserve University, Cleveland, Ohio, 
presented the Twelfth Annual 
Hyman R. Senturia Lecture on 
February 6. She spoke on "Imaging 
of the painful hip and pelvis." 
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response to therapy," "PET 
breast cancer," and "PET 
oncology: beyond FDG" 
it the 26th Annual Course 
Computed Tomography, 
Magnetic Resonance Imaging 
I and Positron Emission 
I Tomography, Auchterarder, 
■ I Scotland, April 9-13. As the 
I Wendell Scott Lecturer, 
•■ Siegel spoke on "Positron 
emission tomography in 
_ breast cancer" at the 32nd 
i National Conference on 
t Breast Cancer, sponsored by 
: the American College of 
] Radiology, San Diego, 
1 California, April 28-30. 
Marilyn Siegel, MD, profes- 
I sor of radiology and of 
pediatrics, spoke on 
"Imaging the child with acute 
abdominal pain" and 
f "Congenital abnormalities" 
I and presented "Advances in 
congenital heart disease 
imaging" at a Special Focus 
Session at St. Luke's Medical 
Center, Quezon City, Phillip- 
ines, March 3. She spoke on 
I "Pediatric pelvic masses," 
"Pediatric hepatic lesions," and 
I "CT of vascular mediastinal 
abnormalities" at the 26th 
Annual Course in Computed 
Tomography, Magnetic Reso- 
nance Imaging and Positron 
Emission Tomography, 
Auchterarder, Scotland, 
April 9-13. 
Lawrence Tarbox, PhD, 
research assistant professor 
of radiology, spoke on 
"Application hosting: a stan- 
dardized API for launching 
and communicating with 
'plug-in' applications" at the 
Open Source Strategy for 
Multi-Center Image Manage- 
ment Conference, Las Vegas, 
I Nevada, March 6-9. He 
presented "Using MIRC to 
access research images in 
a HIPAA world" at Imaging 
Informatics in Focus, the 
2006 Annual Meeting of the 
Society for Computer Appli- 
cations in Radiology, Austin, 
Texas, April 27-30. 
Franz Wippold, MD, profes- 
sor of radiology, presented 
"Imaging and the law: judging 
the book by its cover" at the 
United States Attorney's 
Office of the Eastern District 
Legal Seminar, St. Louis, Mis- 
souri, February 16. He spoke 
on "Imaging the degenerative 
lumbar spine" at the annual 
meeting of the American 
Academy of Orthopedic 
Surgeons, Chicago, Illinois, 
March 24. 
Pamela Woodard, MD, 
associate professor of 
radiology, as visiting professor, 
presented "Delayed contrast- 
enhanced cardiac MR" and 
"Coronary CT angiography" 
at the University of Indiana 
Medical Center, Indianapolis, 
March 1 and 2. She spoke on 
"Evaluation of pulmonary 
arterial hypertension and 
right ventricular function 
with MR" at the Society of 
Thoracic Radiology annual 
meeting, Orlando, Florida, 
March 14. She spoke on 
"Read with the experts: 
CT" at Images to Outcomes 
VI: Cardiovascular Imaging, 
Nuclear Cardiology, and 
Beyond, presented by the 
Division of Nuclear- Medicine 
at Mallinckrodt Institute 
of Radiology and the 
Cardiovascular Division of 
the Department of Medicine, 
St. Louis, Missouri, 
April 28 and 29. 
SYMPOSIA 
In this section ofFYI, only 
those faculty and staff who 
have Department of Radiol- 
ogy appointments are listed. 
SOCIETY OF GASTROIN- 
TESTINAL RADIOLOGISTS 
AND 
SOCIETY OF UR0RADI0L0GY 
Abdominal Radiology 
Course 2006 
Kauai, Hawaii 
February 26—March 3, 2006 
WORKSHOPS 
Dennis Balfe, MD, 
"American Board of 
Radiology: update 2006." 
Jay Heiken, MD, "Cystic 
neoplasms of the pancreas." 
Christine Menias, MD, 
"CT of the right lower 
quadrant pain." 
Sharlene Teefey, MD, 
"Duplex color Doppler 
of liver." 
MULTIDETECTOR CT 
Jay Heiken, MD, "Radiation 
and contrast issues for 
MDCT." 
ABDOMINAL MULTIDETECTOR CT 
Dennis Balfe, MD, moderator 
SELF ASSESSMENT MODULE (SAM) 
Dennis Balfe, MD, "Liver— 
focal benign lesions; focal 
malignant lesions; diffuse 
liver disease." 
ACADEMY OF MOLECULAR 
IMAGING 
Annual Conference 
Orlando, Florida 
March 25-29, 2006 
Barry Siegel, MD, "An 
overview of the National 
Oncologic PET Registry." 
PLENARY SESSIONS 
Gynecological and Breast Cancers 
Farrokh Dehdashti, MD, 
"PET/CT in ovarian and uter- 
ine cancer." 
Perry Grigsby, MD, "PET 
imaging of cervical cancer." 
Role of Imaging in Diabetes 
Robert Gropler, MD, 
"Imaging of substrate 
metabolism in diabetes." 
Radiotracer Imaging in 
Heart Failure—The Role 
of Molecular Imaging 
Robert Gropler, MD, 
"Imaging metabolism in 
heart failure." 
SOCIETY OF INTERVEN- 
TIONAL RADIOLOGY 
31st Annual 
Scientific Meeting 
Toronto, Ontario 
March 30—April 4, 2006 
CATEGORICAL COURSES 
Daniel Brown, MD, 
panelist, Case Based Review: 
Non-vascular Interventions. 
Michael Darcy, MD, 
moderator, GI Bleeding; 
panelist, Case Based Review: 
Non-vascular Intervention; 
"Introduction to course and 
MOC self assessment"; 
"Pre-procedure clinical 
assessment and management"; 
"Update on results for bleed- 
ing and ascetic indications." 
Jennifer Gould, MD, "Man- 
agement of lower GI bleeding." 
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PLENARY SESSIONS 
Daniel Brown, MD, "Abla- 
tion of hepatic malignancy: 
When are we helping the 
patient and when are we 
kidding ourselves?" 
Suresh Vedantham, MD, 
moderator, Venous Throm- 
boembolic disease: Big 
Problem, No Easy Answers; 
"Lower extremity DVT: When 
is intervention indicated?' 
WORKSHOPS 
Daniel Brown, MD, coordi- 
nator, Gastrointestinal IR: 
Techniques and Manage- 
ment. 
Suresh Vedantham, MD, 
coordinator, Thrombolytic 
Therapy for Venous Throm- 
bolysis Disease. 
SOCIETY OF COMPUTED 
BODY TOMOGRAPHY AND 
MAGNETIC RESONANCE 
29th Annual Course 
Phoenix, Arizona 
April 3-7, 2006 
GASTROINTESTINAL IMAGING 
Kyongtae Bae, MD, PhD, 
"PET/CT of the abdomen 
and pelvis: strengths and 
weaknesses from a body 
imager's perspective"; "Prin- 
ciples and practice of con- 
trast material delivery in 
MDCT"; "Interactive case 
review: GI." 
Dennis Balfe, MD, "MDCT 
for diagnosing ischemia 
of the small bowel and 
mesentery." 
Marilyn Siegel, MD, 
"MDCT in children: 
techniques, applications and 
risks"; "CT/MR of pediatric 
mediastinal masses." 
GENITOURINARY IMAGING 
Dennis Balfe, MD, "Imag- 
ing of the subperitoneum: 
What is it and why is it 
important?" 
THORACIC IMAGING 
Stuart Sagel, MD, 
moderator, Thoracic Imag- 
ing—Session II; "Lung can- 
cer screening: status in 
2006"; "CT of the pleura"; 
"Interactive case review: 
chest." 
IMAGING SCIENCES 
RETREAT 
St. Louis, Missouri 
April 21 and 22, 2006 
EDUCATION IN 
IMAGING SCIENCES 
Carolyn Anderson, PhD, 
"Graduate education in 
imaging sciences at WU." 
STATE-OF-THE-ART IN 
BIOMEDICAL IMAGING AT 
WASHINGTON UNIVERSITY 
Joseph Ackerman, PhD; 
Robert Gropler, MD, 
moderators. 
Gilbert Jost, MD, introduc- 
tion, keynote presentation. 
Editor's Note: An abstract presented at the Society 
for Molecular Imaging (listed on page 31 in the 
Winter 2005/2006 issue of Focal Spot) should 
have read as follows: Scott Harpstrite; Julie Prior; 
Jiling Song; David Piwnica-Worms, MD, PhD; Vijay 
Sharma, PhD, """Technetium-complexes for 
imaging /j-amyloid in the brain." 
Mark Mintun, MD, "The 
Center for Clinical Imaging 
Research at WU." 
David Piwnica-Worms, 
MD, PhD, "Molecular imag- 
ing and high throughput 
screening as real time dis- 
covery tools in vivo." 
Marcus Raichle, MD, 
"Neuroimaging at Washing- 
ton University." 
Michael Welch, PhD, "NIH 
translational POl and R24 
grants supporting imaging 
research at WU." 
IMAGING SCALES IN 
TIME AND SPACE 
Joseph Culver, PhD, 
moderator. 
Joseph O'Sullivan, MD, 
PhD, "Image reconstruction 
as optimal information 
extraction." 
PUSHING THE LIMITS OF 
IMAGING 
Steven Petersen, PhD, 
"Studying cognitive develop- 
ment and task control in 
humans with MRI." 
AMERICAN ROENTGEN 
RAY SOCIETY 
106th Annual Meeting 
Vancouver; British Columbia 
April 'SO—May 5, 2006 
CASE-BASED IMAGING 
REVIEW: CARDIOVASCULAR 
IMAGING 
Sanjeev Bhalla, MD, 
"Pericardial disease"; 
"CT angiography of the 
pulmonary arteries." 
Cylen Javidan-Nejad, MD, 
"Myocardial." 
CASE-BASED IMAGING 
REVIEW: GASTROINTESTINAL 
IMAGING 
Christine Menias, MD, 
"CT evaluation of nontrau- 
matic abdominal pain." 
Pamela Woodard, MD, 
"Read cases with the 
experts: abdominal." 
CASE-BASED IMAGING 
REVIEW: THORACIC IMAGING 
Fernando Gutierrez, MD, 
"MDCT: Principles and 
applications in the thorax." 
CATEGORICAL COURSE ON 
BODY MRI 
Marilyn Siegel, MD, "MRI 
of bone marrow." 
Pamela Woodard, MD, 
"MRI of chest pain in the 
young"; "Read cases with 
the experts: cardiac imaging." 
SCIENTIFIC SESSIONS 
Pamela Woodard, MD, 
"MRI of chest pain in 
the young." 
Marilyn Siegel, MD, "Pedi- 
atric mediastinum: vascular 
and nonvascular masses." 
INTRODUCTION TO 
RESEARCH PROGRAM 
Pamela Woodard, MD, 
"Research funding 
opportunities." 
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